CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers
Clinical trial NCT00822809 · COMPLETED
Trial details
- NCT number
- NCT00822809
- Sponsor
- Neovii Biotech
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2010-11-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.